[PHARMA] QoQ TTM Result on 30-Jun-2002 [#2]

Stock
[PHARMA] PHARMANIAGA BHD
Announcement Date
26-Aug-2002
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2002
Quarter
30-Jun-2002 [#2]
Profit Trend
QoQ- 15.5%
YoY- 44.94%
Quarter Report
Latest QR
Upcoming QR
PHARMA's Result
PHARMA's Financial Summary
View:
Show?
TTM Result
31/03/03 31/12/02 30/09/02 30/06/02 31/03/02 31/12/01 30/09/01 CAGR
Revenue 599,086 585,237 594,966 578,889 553,176 543,496 503,335 12.32%
PBT 65,591 61,170 64,797 58,312 52,093 51,604 44,517 29.51%
Tax -23,946 -23,829 -26,084 -24,033 -22,413 -20,800 -20,440 11.14%
NP 41,645 37,341 38,713 34,279 29,680 30,804 24,077 44.14%
-
NP to SH 41,645 37,341 38,713 34,279 29,680 30,804 24,077 44.14%
-
Tax Rate 36.51% 38.96% 40.25% 41.21% 43.02% 40.31% 45.92% -
Total Cost 557,441 547,896 556,253 544,610 523,496 512,692 479,258 10.60%
-
Net Worth 192,761 179,444 172,829 159,457 167,817 160,519 151,781 17.29%
Dividend
31/03/03 31/12/02 30/09/02 30/06/02 31/03/02 31/12/01 30/09/01 CAGR
Div 3,744 3,744 5,002 3,750 3,750 3,750 2,509 30.61%
Div Payout % 8.99% 10.03% 12.92% 10.94% 12.64% 12.18% 10.42% -
Equity
31/03/03 31/12/02 30/09/02 30/06/02 31/03/02 31/12/01 30/09/01 CAGR
Net Worth 192,761 179,444 172,829 159,457 167,817 160,519 151,781 17.29%
NOSH 100,396 99,691 50,095 49,986 49,945 50,006 49,928 59.37%
Ratio Analysis
31/03/03 31/12/02 30/09/02 30/06/02 31/03/02 31/12/01 30/09/01 CAGR
NP Margin 6.95% 6.38% 6.51% 5.92% 5.37% 5.67% 4.78% -
ROE 21.60% 20.81% 22.40% 21.50% 17.69% 19.19% 15.86% -
Per Share
31/03/03 31/12/02 30/09/02 30/06/02 31/03/02 31/12/01 30/09/01 CAGR
RPS 596.72 587.05 1,187.67 1,158.09 1,107.56 1,086.86 1,008.12 -29.52%
EPS 41.48 37.46 77.28 68.58 59.42 61.60 48.22 -9.55%
DPS 3.73 3.76 10.00 7.50 7.50 7.50 5.00 -17.76%
NAPS 1.92 1.80 3.45 3.19 3.36 3.21 3.04 -26.40%
Adjusted Per Share Value based on latest NOSH - 49,986
31/03/03 31/12/02 30/09/02 30/06/02 31/03/02 31/12/01 30/09/01 CAGR
RPS 41.57 40.61 41.28 40.17 38.38 37.71 34.92 12.33%
EPS 2.89 2.59 2.69 2.38 2.06 2.14 1.67 44.18%
DPS 0.26 0.26 0.35 0.26 0.26 0.26 0.17 32.77%
NAPS 0.1337 0.1245 0.1199 0.1106 0.1164 0.1114 0.1053 17.27%
Price Multiplier on Financial Quarter End Date
31/03/03 31/12/02 30/09/02 30/06/02 31/03/02 31/12/01 30/09/01 CAGR
Date 31/03/03 31/12/02 30/09/02 28/06/02 29/03/02 31/12/01 27/09/01 -
Price 3.64 3.80 7.68 7.32 7.32 7.27 5.73 -
P/RPS 0.61 0.65 0.65 0.63 0.66 0.67 0.57 4.62%
P/EPS 8.78 10.15 9.94 10.67 12.32 11.80 11.88 -18.27%
EY 11.40 9.86 10.06 9.37 8.12 8.47 8.42 22.40%
DY 1.02 0.99 1.30 1.02 1.02 1.03 0.87 11.19%
P/NAPS 1.90 2.11 2.23 2.29 2.18 2.26 1.88 0.70%
Price Multiplier on Announcement Date
31/03/03 31/12/02 30/09/02 30/06/02 31/03/02 31/12/01 30/09/01 CAGR
Date 20/05/03 10/04/03 22/11/02 26/08/02 21/05/02 20/02/02 26/11/01 -
Price 3.69 3.62 7.36 7.86 7.86 6.77 6.82 -
P/RPS 0.62 0.62 0.62 0.68 0.71 0.62 0.68 -5.97%
P/EPS 8.90 9.66 9.52 11.46 13.23 10.99 14.14 -26.57%
EY 11.24 10.35 10.50 8.72 7.56 9.10 7.07 36.25%
DY 1.01 1.04 1.36 0.95 0.95 1.11 0.73 24.18%
P/NAPS 1.92 2.01 2.13 2.46 2.34 2.11 2.24 -9.77%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment